RIDD

• Dacarbazine
• Liposome encapsulated recombinant interleukin-2
• Cisplatin

Name

Dacarbazine

Alternate Names

Deticene

Detimedac

Dimethyl-triazeno-imidazole-carboxamide

DTIC-Dome

Fauldetic

Imidazole carboxamide

WR-139007

Abbreviations

DIC

DTIC

ICDT

ICT

Category

Chemotherapy

Subcategory

Antimetabolite

Nonclassic alkylating agent

NSC Number

45388

045388

Primary Site

Hodgkin's disease

melanoma

Neuroblastoma

Soft tissue sarcomas

Histology

None

Remarks

FDA approved on Hodgkin's lymphoma, and metastatic melanoma.

Coding

This drug should be coded

Name

Liposome encapsulated recombinant interleukin-2

Alternate Names

None

Abbreviations

None

Category

Biologic therapy (BRM, immunotherapy)

Subcategory

None

NSC Number

None

Primary Site

None

Histology

None

Remarks

Treatment of brain and CNS, kidney and renal pelvis tumors.

Coding

This drug should be coded

Name

Cisplatin

Alternate Names

Cis-Platin

Cis-Platinum II#

Cisplatino (Spanish)

Cisplatinum

Cisplatyl

Neoplatin

Peyrone's chloride

Platinex

Platinol

Platinol-AQ

Platinol-AQ VHA Plus

Platinum

Abbreviations

CACP

CDDP

Cis-DDP

CPD

CPDC

CPDD

CPPD

DDP

Category

Chemotherapy

Subcategory

Alkylating agent

Platinum analog

NSC Number

119875

Primary Site

Bladder

ovarian

testicular cancer

Histology

None

Remarks

An alkylating antineoplastic agent. FDA approved uses on bladder, ovarian and testicular cancer; miscellaneous agent.

Coding

This drug should be coded